Skip to content
Tariffs and dutiesCommerce BISUnited StatesExports

Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclamation 11020

4 August 2026

In plain English

Proclamation 11020 cuts the tariff on patented pharmaceuticals and pharmaceutical ingredients that are products of the United Kingdom from 10 percent to zero percent.

Read the official notice
Topic
Tariffs and duties
Regulator
Commerce BIS
Published
4 August 2026
For
Exports
Where it applies
United States

From the notice

This notice revises the tariff rate on patented pharmaceuticals and associated pharmaceutical ingredients that are products of the United Kingdom from 10 percent to zero percent in accordance with Proclamation 11020 "Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States."

Olive tells you which of these hit your products.

Olive reads every change like these against your own products, codes and trade lanes, whether you import, export or both, and drafts the update to your compliance program for your approval. Nothing changes without you.

Olivra lists official notices for information only. It is not legal advice, and Olive is not a lawyer or a licensed customs broker. The official text at the source is what counts.

More from Commerce BIS

See everything Olive monitors